MedPath

The therapeutic effect evaluation of the diagnosis and treatment mode of metabolic syndrome by the combination of interactive comprehensive management and Traditional Chinese medicine

Phase 1
Conditions
metabolic syndrome
Registration Number
ITMCTR2000003565
Lead Sponsor
Shuguang Hospital Affiliated to Shanghai Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. sign the informed consent
2. Aged 40 to 70 years old;
3. New diagnosis of MS, or previous diagnosis of MS, poor control of hypoglycemic, hypotensive, lipid-lowering drugs, or obesity.BMI<=35, blood glucose <16,7mmol/L, HbA1c < 9%, systolic blood pressure < 180mmHg, diastolic blood pressure < 110mmHg.
In line with the standard of TCM syndrome diagnosis

Exclusion Criteria

1. Type I diabetes, diabetic ketoacidosis, ketoacidosis and seriously infected persons;
2. Allergic constitution;
3. Women who are pregnant or preparing to be pregnant or breast-feeding;
4. Recent operation, infection, myocardial infarction and other stress states;
5. Patients with serious heart, liver, kidney, brain, blood system complications or other serious primary diseases, psychiatric patients (ALT, BUN, Cr increased by more than 1.5 times);
6. Those who did not agree with the author (who could not cooperate with the diet control, or did not take the medicine according to the regulation, which affected the curative effect).

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hba1c;Fasting lipid profile;flow-mediated dilation;Fasting/postprandial blood glucose;endothelial injury marker;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath